LONOX Drug Patent Profile
✉ Email this page to a colleague
When do Lonox patents expire, and when can generic versions of Lonox launch?
Lonox is a drug marketed by Fosun Pharma and is included in one NDA.
The generic ingredient in LONOX is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LONOX?
- What are the global sales for LONOX?
- What is Average Wholesale Price for LONOX?
Summary for LONOX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Patent Applications: | 60 |
| DailyMed Link: | LONOX at DailyMed |
US Patents and Regulatory Information for LONOX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fosun Pharma | LONOX | atropine sulfate; diphenoxylate hydrochloride | TABLET;ORAL | 085311-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
